Genome-wide analysis of hepatic gene silencing in hepatoma cell variants

Genomics

Volumn 100, Issue 3, 2012, Pages 176-183

  Bulla, Gary A ^a   Aylmer, Caitlin M ^a   Dust, Adele L ^a   Kurkewich, Jeffrey L ^a   Mire, Leon K ^a   Estanda, Arnold B ^a  

^a EASTERN ILLINOIS UNIVERSITY   (United States)

Author keywords

Cell variants; Hepatic; Hepatoma; Microarray

Indexed keywords

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE ACTIVATION; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE REPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC ASSOCIATION; GENOME ANALYSIS; HEPATOMA CELL; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROMOTER REGION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR GENE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE SILENCING; GENETIC VECTORS; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; LIVER; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RATS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TRANSGENES;

RATTUS;

EID: 84865400499     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2012.05.010     Document Type: Article

References (45)

1. Bulla G.A. Selective loss of the hepatic phenotype due to the absence of a transcriptional activation pathway. Somat. Cell Mol. Genet. 1997, 23:185-201.
2. Cereghini S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J. 1996, 10:267-282.
3. Costa R.H., Kalinichenko V.V., Holterman A.X., Wang X. Transcription factors in liver development, differentiation and regeneration. Hepatology 2003, 38:1331-1347.
4. Odom D.T., Dowell R.D., Jacobsen E.S., Nekludova L., Rolfe P.A., Danford T.W., Gifford D.K., Fraenkel E., Bell G.I., Young R.A. Core transcriptional regulatory circuitry in human hepatocytes. Mol. Syst. Biol. 2006, 2:2006.0017.
5. Bulla G.A. Hepatocyte nuclear factor-4 prevents silencing of hepatocyte nuclear factor-1 expression in hepatoma×fibroblast cell hybrids. Nucleic Acids Res. 1997, 25:2501-2508.
6. Kuo C.J., Conley P.B., Chen L., Sladek F.M., Darnell J.E., Crabtree G.R. A transcriptional hierarchy involved in mammalian cell-type specification. Nature 1992, 355:457-461.
7. Duncan S.A., Navas M.A., Dufort D., Rossant J., Stoffel M. Regulation of a transcription factor network required for differentiation and metabolism. Science 1998, 281:692-695.
8. Lee C.S., Friedman J.R., Fulmer J.T., Kaestner K.H. The initiation of liver development is dependent on Foxa transcription factors. Nature 2005, 435:944-947.
9. Odom D.T., Zizlsperger N., Gordon D.B., Bell G.W., Rinaldi N.J., Murray H.L., Volkert T.L., Schreiber J., Rolfe P.A., Gifford D.K., Fraenkel E., Bell G.I., Young R.A. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004, 303:1378-1381.
10. Cassio D., Rogier E., Feldmann G., Weiss M.C. Plasma-protein production by rat hepatoma cells in culture, their variants and revertants. Differentiation 1986, 30:220-228.
11. Deschatrette J., Moore E.E., Dubois M., Weiss M.C. Dedifferentiated variants of a rat hepatoma: reversion analysis. Cell 1980, 19:1043-1051.
12. Deschatrette J., Weiss M.C. Characterization of differentiated and dedifferentiated clones from a rat hepatoma. Biochimie 1974, 56:1603-1611.
13. Bulla G.A., Givens E., Brown S., Oladiran B., Kraus D. A common regulatory locus affects both HNF4/HNF1a pathway activation and sensitivity to LPS-mediated apoptosis in rat hepatoma cells. J. Cell Sci. 2001, 114:1205-1212.
14. Bulla G.A., Fournier R.E. Genetic analysis of a transcriptional activation pathway by using hepatoma cell variants. Mol. Cell. Biol. 1994, 14:7086-7094.
15. Bulla G.A., Kraus D.A. Dissociation of the hepatic phenotype from HNF4 and HNF1a expression. Biosci. Rep. 2005, 24:595-608.
16. Rollini P., Fournier R.E. The HNF-4/HNF-1alpha transactivation cascade regulates gene activity and chromatin structure of the human serine protease inhibitor gene cluster at 14q32.1. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10308-10313.
17. Rollini P., Xu L., Fournier R.E. Partial activation of gene activity and chromatin remodeling of the human 14q32.1 serpin gene cluster by HNF-1 alpha and HNF-4 in fibroblast microcell hybrids. Somat. Cell Mol. Genet. 1999, 25:207-221.
18. Bulla G.A., Batanian J.R., Young H.M., Bradley N., Kazi N., Haddad B.R. Rescue of the HNF4/HNF1 pathway in hepatoma variant cells containing human chromosome 12. Genomics 1998, 54:398-407.
19. Bulla G.A., Fournier R.E. Direct selection of hepatoma cell variants deficient in alpha 1-antitrypsin gene expression. Somat. Cell Mol. Genet. 1992, 18:361-370.
20. Bulla G.A. Extinction of a1-antitrypsin expression in cell hybrids is independent of HNF1a and HNF4 and involves both promoter and internal DNA sequences. Nucleic Acids Res. 1999, 27:1190-1197.
21. Guo L., Xia Q., Dial S., Chan P.C., Fu P. Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract. Food Chem. Toxicol. 2009, 47:433-442.
22. Bulla G.A., Luong Q., Shrestha S., Reeb S., Hickman S. Genome-wide analysis of hepatic gene silencing in mammalian cell hybrids. Genomics 2010, 96:323-332.
23. Cereghini S., Blumenfeld M., Yaniv M. A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells. Genes Dev. 1988, 2:957-974.
24. Kraus D., Bulla G.A. Defective NF-kB signaling in dedifferentiated hepatoma cells. Somat. Cell Mol. Genet. 2002, 27:275-286.
25. Spath G.F., Weiss M.C. Hepatocyte nuclear factor 4 expression overcomes repression of the hepatic phenotype in dedifferentiated hepatoma cells. Mol. Cell. Biol. 1997, 17:1913-1922.
26. Schmitz A.K., Kraus D.M., Bulla G.A. Tissue-specificity of apoptosis in hepatoma derived cell lines. Apoptosis 2004, 9:369-375.
27. Marsden M.D., Fournier R.E. Organization and expression of the human serpin gene cluster at 14q32.1. Front. Biosci. 2005, 10:1768-1778.
28. Baxter E.W., Cummings W.J., Fournier R.E. Formation of a large, complex domain of histone hyperacetylation at human 14q32.1 requires the serpin locus control region. Nucleic Acids Res. 2005, 33:3313-3322.
29. Rollini P., Fournier R.E.K. The HNF4/HNF1a transactivation cascade regulates gene activity and chromatin structure of the human serine protease inhibitor cluster at 14q32.1. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10308-10313.
30. Thomas P.Q., Brown A., Beddington R.S. Hex: a homeobox gene revealing peri-implantation asymmetry in the mouse embryo and an early transient marker of endothelial cell precursors. Development 1998, 125:85-94.
31. Hallaq H., Pinter E., Enciso J., McGrath J., Zeiss C., Brueckner M., Madri J., Jacobs H.C., Wilson C.M., Vasavada H., Jiang X., Bogue C.W. A null mutation of Hhex results in abnormal cardiac development, defective vasculogenesis and elevated Vegfa levels. Development 2004, 131:5197-5209.
32. Hwa V., Oh Y., Rosenfeld R.G. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr. Rev. 1999, 20:761-787.
33. Veal E., Eisenstein M., Tseng Z.H., Gill G. A cellular repressor of E1A-stimulated genes that inhibits activation by E2F. Mol. Cell. Biol. 1998, 18:5032-5041.
34. Yamada K., Ogata-Kawata H., Matsuura K., Miyamoto K. SHARP-2/Stra13/DEC1 as a potential repressor of phosphoenolpyruvate carboxykinase gene expression. FEBS Lett. 2005, 579:1509-1514.
35. Nakashima A., Kawamoto T., Honda K.K., Ueshima T., Noshiro M., Iwata T., Fujimoto K., Kubo H., Honma S., Yorioka N., Kohno N., Kato Y. DEC1 modulates the circadian phase of clock gene expression. Mol. Cell. Biol. 2008, 28:4080-4092.
36. Masaki H., Nishida T., Kitajima S., Asahina K., Teraoka H. Developmental pluripotency-associated 4 (DPPA4) localized in active chromatin inhibits mouse embryonic stem cell differentiation into a primitive ectoderm lineage. J. Biol. Chem. 2007, 282:33034-33042.
37. Kim S.K., Suh M.R., Yoon H.S., Lee J.B., Oh S.K., Moon S.Y., Moon S.H., Lee J.Y., Hwang J.H., Cho W.J., Kim K.S. Identification of developmental pluripotency associated 5 expression in human pluripotent stem cells. Stem Cells 2005, 23:458-462.
38. Lee K.K., Tang M.K., Yew D.T., Chow P.H., Yee S.P., Schneider C., Brancolini C. gas2 is a multifunctional gene involved in the regulation of apoptosis and chondrogenesis in the developing mouse limb. Dev. Biol. 1999, 207:14-25.
39. Lu P., Prost S., Caldwell H., Tugwood J.D., Betton G.R., Harrison D.J. Microarray analysis of gene expression of mouse hepatocytes of different ploidy. Mamm. Genome 2007, 18:617-626.
40. Xu Y., Qu X., Zhang X., Luo Y., Zhang Y., Hou K., Liu Y. Midkine positively regulates the proliferation of human gastric cancer cells. Cancer Lett. 2009, 279:137-144.
41. Ochiai K., Muramatsu H., Yamamoto S., Ando H., Muramatsu T. The role of midkine and pleiotrophin in liver regeneration. Liver Int. 2004, 24:484-491.
42. Giannini A.L., Gao Y., Bijlmakers M.J. T-cell regulator RNF125/TRAC-1 belongs to a novel family of ubiquitin ligases with zinc fingers and a ubiquitin-binding domain. Biochem. J. 2008, 410:101-111.
43. Shoji-Kawata S., Zhong Q., Kameoka M., Iwabu Y., Sapsutthipas S., Luftig R.B., Ikuta K. The RING finger ubiquitin ligase RNF125/TRAC-1 down-modulates HIV-1 replication in primary human peripheral blood mononuclear cells. Virology 2007, 368:191-204.
44. Sapin V., Bouillet P., Oulad-Abdelghani M., Dastugue B., Chambon P., Dolle P. Differential expression of retinoic acid-inducible (Stra) genes during mouse placentation. Mech. Dev. 2000, 92:295-299.
45. Moser M., Imhof A., Pscherer A., Bauer R., Amselgruber W., Sinowatz F., Hofstadter F., Schule R., Buettner R. Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. Development 1995, 121:2779-2788.